Categories AlphaGraphs, Earnings, Health Care
WBA Earnings: Walgreens Boots Alliance reports higher Q1 sales; results beat
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Friday reported an increase in net sales for the first quarter of 2025. Both sales and profit exceeded estimates.
Earnings, excluding special items, decreased to $0.51 per share in the first quarter from $0.66 per share in the corresponding period last year but came in above analysts’ forecast. On an unadjusted basis, it was a net loss of $265 million or $0.31 per share in Q1, compared to a loss of $67 million or $0.08 per share in the prior year period.
Net sales increased 7.5% year-over-year to $39.5 billion in the November quarter and exceeded estimates. The company maintained its fiscal 2025 adjusted EPS guidance of $1.40 to $1.80.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DIS Earnings: All you need to know about Walt Disney’s Q4 2025 earnings results
The Walt Disney Company (NYSE: DIS) reported its fourth quarter 2025 earnings results today. Revenues of $22.5 billion were comparable to the year-ago quarter. Net income attributable to The Walt
Cisco (CSCO) reports higher Q1 revenue and earnings; results beat estimates
Network gear maker Cisco Systems Inc. (NASDAQ: CSCO) on Wednesday announced financial results for the first quarter of fiscal 2026, reporting higher revenue and profit. Earnings, on an adjusted basis,
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on hematologic malignancies and solid tumors. In an email conversation with
